论文部分内容阅读
目的探讨来曲唑治疗多囊卵巢综合征患者的临床疗效。方法回顾性分析2014年10月至2015年12月104例多囊卵巢综合征患者的临床资料,依据治疗方式分为实验组和对照组,两组患者分别接受来曲唑、氯米芬疗法,分析两组患者的各项疗效指标和排卵结局。结果实验组排卵数、优势排卵数等疗效指标明显优于对照组(P<0.05);实验组妊娠率为51.92%,明显高于对照组(32.69%)(P<0.05)。结论来曲唑可以明显提高多囊卵巢综合征不孕患者的妊娠率,值得在今后的临床治疗中继续推广使用。
Objective To investigate the clinical efficacy of letrozole in patients with polycystic ovary syndrome. Methods The clinical data of 104 patients with PCOS from October 2014 to December 2015 were retrospectively analyzed. According to the treatment methods, the patients were divided into experimental group and control group. Patients in both groups received letrozole and clomiphene therapy, Analysis of the two groups of patients with various efficacy indicators and ovulation outcomes. Results The number of ovulation and the number of dominant ovulation in the experimental group were significantly better than those in the control group (P <0.05). The pregnancy rate in the experimental group was 51.92%, significantly higher than that in the control group (32.69%, P <0.05). Conclusion Letrozole can significantly improve the pregnancy rate of patients with polycystic ovary syndrome infertility, it is worth in the future clinical treatment continue to promote the use of.